Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00400335 · ClinicalTrials.gov registry record · Phase 1
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT00400335 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 60 participants.
The verdict
NCT00400335, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
Interventions
- DRUG Nanomilled testosterone
- DRUG Nanomilled dutasteride
- DRUG commercially available dutasteride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00400335
The ClinicalTrials.gov registry entry for NCT00400335 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nanomilled testosterone is the first listed.
NCT00400335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00400335 about?
NCT00400335 is a clinical study titled "Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride". The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
What is the current status of trial NCT00400335?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2006-10.
What interventions are being tested in trial NCT00400335?
The interventions under investigation include: Nanomilled testosterone (DRUG), Nanomilled dutasteride (DRUG), commercially available dutasteride (DRUG).
Who is sponsoring clinical trial NCT00400335?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.